We are live on ! Find out more
SP

Steelhead Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 0.34%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+0.34%
3 Year Est. Return
+0.4%
5 Year Est. Return
+0.39%
10 Year Est. Return
+5.72%
AUM
$1.17B
AUM Growth
-$289M
Cap. Flow
-$1.07B
Cap. Flow %
-92.14%
Top 10 Hldgs %
51.97%
Holding
41
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CNMD icon
CONMED
CNMD
+$958K

Top Sells

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$106K

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.93%
2 Healthcare 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNMD icon
1
CONMED
CNMD
$1.48B
$764K 0.07%
+7,980
New +$958K
PGEN icon
2
Precigen
PGEN
$2.54B
– –
-50,000
Closed -$106K

Similar funds

RIA
Retirement Investment Advisors Oklahoma City, Oklahoma $1.4B AUM 17.23% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.4B AUM 23.96% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.4B AUM 36.82% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
1SP
140 Summer Partners New York $1.4B AUM 73.38% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
ASA
Axxion S.A. Grevenmacher, Luxembourg $1.41B AUM

Steelhead Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Steelhead Partners held 41 positions worth $1.17B, down 20% from $1.45B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Steelhead Partners withdrew a net $1.07B in Q2 2022, closing 1 position. Its most notable exit was Precigen, an estimated $106K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, down from 100% a quarter earlier, followed by Healthcare.

Against the trend, Steelhead Partners opened a new position in CONMED worth $764K.

  • Steelhead Partners's largest Q2 2022 buy was CONMED: 7,980 shares worth $764K.
  • Steelhead Partners fully exited Precigen in Q2 2022, selling an estimated $106K.
  • Steelhead Partners's ten largest holdings make up 52% of its $1.17B portfolio in Q2 2022.
  • Steelhead Partners opened 1 new position and closed 1 in Q2 2022.
  • Steelhead Partners's portfolio value fell 20% quarter-over-quarter to $1.17B.

Based on Steelhead Partners's 13F filing for Q2 2022, filed 16 Aug 2022.